Mortality risks not increased by external beam RT in early-stage breast cancer
 

Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting...

More...